These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Troxerutin improves hepatic lipid homeostasis by restoring NAD(+)-depletion-mediated dysfunction of lipin 1 signaling in high-fat diet-treated mice. Zhang ZF; Fan SH; Zheng YL; Lu J; Wu DM; Shan Q; Hu B Biochem Pharmacol; 2014 Sep; 91(1):74-86. PubMed ID: 25026599 [TBL] [Abstract][Full Text] [Related]
4. Chaperonin counteracts diet-induced non-alcoholic fatty liver disease by aiding sirtuin 3 in the control of fatty acid oxidation. Weng SW; Wu JC; Shen FC; Chang YH; Su YJ; Lian WS; Tai MH; Su CH; Chuang JH; Lin TK; Liou CW; Chu TH; Kao YH; Wang FS; Wang PW Diabetologia; 2023 May; 66(5):913-930. PubMed ID: 36692509 [TBL] [Abstract][Full Text] [Related]
5. Pancreatic Sirtuin 3 Deficiency Promotes Hepatic Steatosis by Enhancing 5-Hydroxytryptamine Synthesis in Mice With Diet-Induced Obesity. Ming X; Chung ACK; Mao D; Cao H; Fan B; Wong WKK; Ho CC; Lee HM; Schoonjans K; Auwerx J; Rutter GA; Chan JCN; Tian XY; Kong APS Diabetes; 2021 Jan; 70(1):119-131. PubMed ID: 33087457 [TBL] [Abstract][Full Text] [Related]
6. P2Y2R Deficiency Ameliorates Hepatic Steatosis by Reducing Lipogenesis and Enhancing Fatty Acid β-Oxidation through AMPK and PGC-1α Induction in High-Fat Diet-Fed Mice. Dusabimana T; Park EJ; Je J; Jeong K; Yun SP; Kim HJ; Kim H; Park SW Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34073834 [TBL] [Abstract][Full Text] [Related]
8. Dihydromyricetin Ameliorates Nonalcoholic Fatty Liver Disease by Improving Mitochondrial Respiratory Capacity and Redox Homeostasis Through Modulation of SIRT3 Signaling. Zeng X; Yang J; Hu O; Huang J; Ran L; Chen M; Zhang Y; Zhou X; Zhu J; Zhang Q; Yi L; Mi M Antioxid Redox Signal; 2019 Jan; 30(2):163-183. PubMed ID: 29310441 [No Abstract] [Full Text] [Related]
9. Nrf2 Activation Is Required for Ligustrazine to Inhibit Hepatic Steatosis in Alcohol-Preferring Mice and Hepatocytes. Lu C; Xu W; Shao J; Zhang F; Chen A; Zheng S Toxicol Sci; 2017 Feb; 155(2):432-443. PubMed ID: 27837167 [TBL] [Abstract][Full Text] [Related]
10. PEGylated Curcumin Derivative Attenuates Hepatic Steatosis via CREB/PPAR- Liu Y; Cheng F; Luo Y; Zhan Z; Hu P; Ren H; Tang H; Peng M Biomed Res Int; 2017; 2017():8234507. PubMed ID: 28770225 [TBL] [Abstract][Full Text] [Related]
11. SIRT3 Deficiency Promotes High-Fat Diet-Induced Nonalcoholic Fatty Liver Disease in Correlation with Impaired Intestinal Permeability through Gut Microbial Dysbiosis. Chen M; Hui S; Lang H; Zhou M; Zhang Y; Kang C; Zeng X; Zhang Q; Yi L; Mi M Mol Nutr Food Res; 2019 Feb; 63(4):e1800612. PubMed ID: 30525304 [TBL] [Abstract][Full Text] [Related]
12. Bixin Attenuates High-Fat Diet-Caused Liver Steatosis and Inflammatory Injury through Nrf2/PPAR Tao S; Yang Y; Li J; Wang H; Ma Y Oxid Med Cell Longev; 2021; 2021():6610124. PubMed ID: 33603948 [TBL] [Abstract][Full Text] [Related]